Physician profile
Lori A Gregory
NPI 1275086274
$254.86
in general payments reported to CMS, 2019-2025
11 companies · $92.62 in 2025
The $92.62 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.84 · 2022: $60.66 · 2023: $18.40 · 2024: $41.34 · 2025: $92.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $43.81 | 2021-2025 | Otezla, Repatha |
| Pfizer INC. | $41.77 | 2021-2022 | |
| Novo Nordisk INC | $37.39 | 2022-2025 | Ozempic, Rybelsus |
| Indivior INC. | $24.98 | 2024 | Sublocade |
| Abbott Laboratories | $18.40 | 2023 | Freestyle Libre 3 |
| Insulet Corporation | $16.36 | 2024 | Omnipod |
| Dexcom, INC. | $16.03 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.24 | 2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $14.07 | 2025 | Givlaari |
| Astrazeneca Pharmaceuticals LP | $14.06 | 2025 | Airsupra |
| Lundbeck LLC | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.